Authors


Nash N. Boutros, MD

Latest:

The Electroencephalogram in the Management of Psychiatric Conditions

The electroencephalogram (EEG) has a limited but definitive role in understanding and managing psychiatric conditions. When the presentation is unusual, a neurological workup that includes an EEG is essential.


Natalie L. Rasgon, MD, PhD

Latest:

Investigating Polycystic Ovary Syndrome in Women With Bipolar Disorder

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, and it may manifest as mood disturbances in those affected. How can this medical condition be treated in women who have bipolar disorder?


Natalie Timoshin

Latest:

Tchaikovsky: Music and Melancholy

A virtuoso concert pianist and psychiatrist's "play" on the role of music in healing and the influence of psychological and medical factors on the creative output of the great composers in music history.


Nathan Fairman, MD, MPH

Latest:

Attending to the “Mental Suffering” of Patients With Progressive Medical Illness

Psychiatrists have found ways to bring their expert skills and knowledge to the care of medically ill patients who are nearing the final phase of life.


Nathaniel A. Brown, MD

Latest:

Combat Veterans: Adaptation to Transition

Leaving the military is not an easy or simple process. Here is one psychiatrist's personal story.


Nathaniel Brown, MD

Latest:

Burden, Belonging, and Capability: An Interpersonal View of Military Suicides

It would be logical to attribute the surge of suicides in the military to simultaneous prolonged engagement in combat, repeated deployments, and attendant stress. But studies have failed to connect deployments to suicide risk.


National Network of Depression Centers

Latest:

PatientsLikeMe: Crowdsourced Patient Health Data as a Clinical Tool in Psychiatry

Patients want to know what to expect with a given treatment, how their experiences compare with those of others, or whether they are alone in coping with their conditions. Who best to answer these questions than others like them?


Neal Hermanowicz, MD

Latest:

Clinical Pearls on the Management of Parkinson Disease

The ideal medication for Parkinson disease (PD) would reduce disability and halt or slow disease progression without intolerable adverse effects. Although such an agent is not yet available, current treatments offer significant symptom control for most patients. The decision about when to start therapy is highly individual; however, delaying treatment because of fear of adverse effects may not be in the patient's best interest.


NeedsFixing

Latest:

Introduction: The Integrated Approach to Addressing Comorbidities-Part 1

These articles illustrate the variety and complexity of problems associated with comorbidity in psychiatric disorder.


Neeraj Badjatia, MD

Latest:

Hemicraniectomy for Massive Basal Ganglia Hemorrhage

intracerebral hemorrhage, hemicraniectomy, stroke, neurosurgery, traumatic brain injury


Negar Fani, MS

Latest:

PTSD in the Emergency Setting

The following 3 cases illustrate the diagnostic challenges related to differentiating brain injury and posttraumatic stress disorder (PTSD) in patients presenting to the emergency department (ED) in the acute period following a traumatic injury. Such patients pose a dilemma for ED clinicians because of the interplay between head injury and PTSD in the clinical presentation of cognitive impairments in the aftermath of trauma.


Nehama Dresner, MD

Latest:

Psychiatric Care of Peripartum Women

This article summarizes clinically relevant advances in the psychiatric care of women during and after pregnancy, including recent changes in how the FDA classifies pregnancy risk for medications, and best practices in perinatal psychopharmacology.


Neil B. Sandson, MD

Latest:

Drug-Drug Interactions in Psychopharmacology

Coping with the issue of drug-drug interactions (DDIs) is one of the most challenging aspects of modern psychopharmacology. Psychiatrists are treating patients with medication regimens of ever-increasing complexity.


Neil Krishan Aggarwal, MD, MBA, MA, DFAPA

Latest:

Psychiatrists and Peacemaking: A Cultural Psychiatry Perspective

H. Steven Moffic, MD, interviews Neil Krishan Aggarwal, MD, MBA, MA, DFAPA, on his new book and the concept of peacemaking.


Neil Scheurich, MD

Latest:

Psychiatric Power

The state of North Carolina has relatively liberal policies regarding petitions for involuntary commitment. If such documents bear words like "dangerous" or "mentally ill," even in the most nebulous sense imaginable, the police will surely locate the relevant individuals and dutifully bring them to the emergency department. This generosity of interpretation produces some sticky situations for the lucky ED resident of the day.


Nev Jones, PhD

Latest:

Providing Culturally Competent Care: Understanding the Context of Psychosis

Culture-the way people make meaning and live their lives in particular social worlds-matters in psychosis. The authors explore how a patient's cultural background should influence the way clinicians think about treatment and care.


Nhi-ha Trinh, MD, MPH

Latest:

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment

Bipolar disorder (BD) in later life is a complex and confounding neuropsychiatric syndrome with diagnostic and therapeutic challenges.


Niall McLaren, MBBS, FRANZCP

Latest:

Will Biology Tell Us All We Need to Know About Mental Disorder?

At the very heart of psychiatry, people seem totally unconcerned about making claims that, for example, philosophers have never been able to prove.


Nicholas A. Kozauer, MD

Latest:

Depression in Patients With Alzheimer Dementia

Alzheimer dementia (AD) represents a profound global health concern. By the year 2050, the prevalence of AD in the United States is expected to reach 15 million. At present, there are 4.5 million cases in the United States, which equals an estimated cost of $100 billion each year in medical and family expenses.


Nicholas Demartinis, MD

Latest:

The Effects of Antidepressants on Sleep

Knowledge of how different antidepressants are likely to affect parameters of sleep can provide an important basis for selecting an appropriate antidepressant drug among the roughly 2 dozen marketed options to meet the needs of depressed patients.


Nicholas L. Salsman, PhD

Latest:

Understanding the Usefulness of Psychosocial Interventions for Personality Disorders

An examination of recent research on psychosocial treatments for personality disorders, including randomized controlled trials and empirically supported therapies as well as dialectical behavior therapy.


Nicholas Pediaditakis, MD

Latest:

The Dog That Did Not Bark

Some thoughts on the pathogenesis and persistence of prevalence of schizophrenia and bipolar affective disorder in view of current discoveries.


Nick C. Mellos, MD

Latest:

A Risk Stratification Approach to Alcohol Detoxification

The challenges of identifying patients at risk for alcohol withdrawal have been found to be mitigated by the development of a Risk Stratification Questionnaire, now being adopted by the VA regionally throughout New England. More in this video.


Nick Kanas, MD

Latest:

Psychiatric Issues in Space

The many potential stressors for astronauts during space missions present unique and fascinating 21st century psychiatric and psychological issues.


Nick Phelps

Latest:

A Word From Sandy Hook

It has become clear over the last couple of days that Sandy Hook Elementary School and Newtown have become an area of great concern locally, nationally, and internationally. We as a world community need to go through a grieving process that includes this type of sharing, especially for parents out there.


Nick Thomarios, MD

Latest:

Atypical Antipsychotics for Children and Adolescents With Schizophrenia-Spectrum Disorders

Although the onset of psychotic symptoms before the age of 13 years is exceedingly rare, the incidence of schizophrenia rises sharply after the onset of puberty.1 Only 1% of the population has schizophrenia and 30% of these patients experience an onset of psychotic symptoms by age 18 years.2-8 The period that precedes the onset of frank psychotic symptoms (ie, the prodromal phase) has not been well characterized in early-onset schizophrenia-spectrum disorders (EOSS), but retrospective reports have shown that symptoms include high levels of depression and anxiety, emerging cognitive and social deficits, unusual thought content, and (not infrequently) school failure.


Nicolas Badre, MD

Latest:

Tales of Overconfidence: 3 Stories to Refine Psychiatry

These 3 stories offer a lesson in humility to psychiatry.


Nicole B. Washington, DO

Latest:

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations

A focus on QTc monitoring in patients receiving psychotropics, especially when multiple medications are prescribed.


Nicole Braida, MD

Latest:

The Link Between Immune System Dysregulation and Schizophrenia

On the wide range of symptoms in schizophrenia, including alterations of the dopaminergic and/or glutamatergic systems, abnormal neurodevelopment, and the theory of immune system imbalance.


Nicole Charder, MD

Latest:

Heatstroke and Psychiatric Patients

A variety of commonly used psychiatric medications increase the risk of heatstroke, leaving psychiatric patients in jails and prisons at risk.

© 2025 MJH Life Sciences

All rights reserved.